Tuesday 14 Jan 2025
By
main news image

KUALA LUMPUR (Aug 23): TMC Life Sciences Bhd net profit jumped over six times for the fourth quarter ended June 30, 2022 (4QFY22) driven by increased capacity and higher patient load.

The healthcare group, which is 70%-controlled by Singapore billionaire Peter Lim Eng Hock via Sasteria (M) Pte Ltd, declared a final dividend of 0.28 sen per share with ex-date on Dec 5 this year.

Net profit increased sharply to RM23.47 million or 1.35 sen per share for 4QFY22 from RM3.75 million or 0.22 sen per share a year ago, on the back of 33% growth in revenue to RM70.8 million from RM53.37 million, TMC’s latest stock exchange filing showed.

For the full financial year ended June 30, 2022 (FY22), its annual net profit more than doubled to RM41.39 million from RM20.25 million in FY21, while revenue grew 21% to RM243.77 million from RM201.02 million.

Going forward, the group, in which Johor crown prince Tunku Ismail Ibni Sultan Ibrahim owns a 7.6% stake, said the increased capacity in Thomson Hospital Kota Damansara and recovery of fertility business is expected to contribute positively to its growth.

TMC’s share price went up one sen to 50.5 sen per share on Tuesday, giving it a market capitalisation of RM879.65 million.

Edited ByKathy Fong
      Print
      Text Size
      Share